References
Shirley M, Murphy R. Metabolism of LTB4 by isolated hepatocytes: new metabolites and effect of ethanol. Ann NY Acad Sci 1991;629:410–2.
Chauhan K, Bhatt R, Falck J, Capdevila J. Total synthesis of the ethanol inducible, proinflammatory autocoid 3(S)-hydroxy-LTB4 and analogues. Tetrahedron Lett 1994;35:1825–8.
Shirley M, Reidhead C, Murphy R. Chemotactic LTB4 metabolites produced by hepatocytes in the presence of ethanol. Biochem Biophys Res Comm 1992;185:604–10.
Djuric S, Docter S, Yu S, Tsai B, Anglin C, Gaginella T, et al. Synthesis and pharmacological activity of SC-53228. Bioorgan. Med. Chem. Lett. 1994;4:811–6.
Fretland D, Anglin C, Bremmer M, Isakson P, Widomski D, Paulson S, Docter S, Djuric S, Penning T, Yu S, McKearn J. Anti-inflammatory effects of the second generation leukotriene B4 receptor antagonist, SC-53228. Inflamm. In press.
Bradley P, Priebat D, Christensen R, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–9.
Tsai B, Keith R, Villani-Price D, Kachur J, Yang D, Djuric S, et al. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors. J Pharmacol Exp Therap 1994;268:1499–505.
Djuric S, Fretland D, Penning T. The leukotriene B4 receptor antagonists. Drugs of Future 1992;17:819–30.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fretland, D., Anglin, C., Baron, D. et al. 3(S)-hydroxy-leukotriene B4 is a potent granulocyte chemotaxin in the guinea pig dermis. Inflamm Res 44 (Suppl 2), S137–S138 (1995). https://doi.org/10.1007/BF01778300
Issue Date:
DOI: https://doi.org/10.1007/BF01778300